Literature DB >> 25400417

Deletion and down-regulation of SMAD4 gene in colorectal cancers in a Chinese population.

Yanling Ma1, Fei Yan1, Li Li1, Li Liu1, Jianhai Sun1.   

Abstract

OBJECTIVE: Colorectal cancer (CRC) is one of the most common types of human cancers. As a tumor suppressor, SMAD4 plays a key role in colorectal carcinogenesis and invasiveness. Copy number variations (CNVs) of the SMAD4 gene have been reported to be associated with cancer pathogenesis in array-based studies in different populations. Here we aimed to investigate the CNVs of the SMAD4 gene in a relatively large number of CRC patients from China.
METHODS: In the present study, we collected 147 Chinese CRC tumors as well as self-paired normal control tissues. Quantitative PCR was carried out to examine the copy number as well as the mRNA expression of the SMAD4 gene.
RESULTS: Our results showed that the copy number deletions of SMAD4 were frequent in a relatively high percentage of CRC samples (34.7%, 51 out of 147). There was a positive correlation between the copy number decrease of SMAD4 and tumor progression in CRCs. Furthermore, copy number loss of SMAD4 was correlated with decreased mRNA expression.
CONCLUSIONS: These findings suggested that the copy number deletions of SMAD4 were frequent in CRC patients from China and had the potential to serve as a diagnostic indicator, alone or in combination with other markers, for CRC.

Entities:  

Keywords:  Colorectal cancer (CRC); SMAD4; copy number variation (CNV); gene expression

Year:  2014        PMID: 25400417      PMCID: PMC4220255          DOI: 10.3978/j.issn.1000-9604.2014.09.02

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  27 in total

1.  Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer.

Authors:  J M Carethers; M T Hawn; J K Greenson; C L Hitchcock; C R Boland
Journal:  Gastroenterology       Date:  1998-06       Impact factor: 22.682

Review 2.  TGF-beta signaling in cancer--a double-edged sword.

Authors:  R J Akhurst; R Derynck
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

3.  Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.

Authors:  Silke Lassmann; Roland Weis; Frank Makowiec; Jasmine Roth; Mihai Danciu; Ulrich Hopt; Martin Werner
Journal:  J Mol Med (Berl)       Date:  2006-12-02       Impact factor: 4.599

4.  Antimetastatic role of Smad4 signaling in colorectal cancer.

Authors:  Bixiang Zhang; Sunil K Halder; Nilesh D Kashikar; Yong-Jig Cho; Arunima Datta; D Lee Gorden; Pran K Datta
Journal:  Gastroenterology       Date:  2009-11-10       Impact factor: 22.682

5.  Association studies on 11 published colorectal cancer risk loci.

Authors:  S von Holst; S Picelli; D Edler; C Lenander; J Dalén; F Hjern; N Lundqvist; U Lindforss; L Påhlman; K Smedh; A Törnqvist; J Holm; M Janson; M Andersson; S Ekelund; L Olsson; S Ghazi; N Papadogiannakis; A Tenesa; S M Farrington; H Campbell; M G Dunlop; A Lindblom
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

6.  Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.

Authors:  Kyoko Kojima; Selwyn M Vickers; N Volkan Adsay; Nirag C Jhala; Hyung-Gyoon Kim; Trenton R Schoeb; William E Grizzle; Christopher A Klug
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

7.  Frequent loss of SMAD4/DPC4 protein in colorectal cancers.

Authors:  R Salovaara; S Roth; A Loukola; V Launonen; P Sistonen; E Avizienyte; P Kristo; H Järvinen; S Souchelnytskyi; M Sarlomo-Rikala; L A Aaltonen
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

8.  Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohort.

Authors:  Anneke Middeldorp; Shantie Jagmohan-Changur; Ronald van Eijk; Carli Tops; Peter Devilee; Hans F A Vasen; Frederik J Hes; Richard Houlston; Ian Tomlinson; Jeanine J Houwing-Duistermaat; Juul T Wijnen; Hans Morreau; Tom van Wezel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

9.  Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors.

Authors:  Christine A Iacobuzio-Donahue; Jason Song; Giovanni Parmiagiani; Charles J Yeo; Ralph H Hruban; Scott E Kern
Journal:  Clin Cancer Res       Date:  2004-03-01       Impact factor: 12.531

10.  Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.

Authors:  Lisa G Horvath; Susan M Henshall; James G Kench; Jennifer J Turner; David Golovsky; Phillip C Brenner; Gordon F O'Neill; Raji Kooner; Phillip D Stricker; John J Grygiel; Robert L Sutherland
Journal:  Prostate       Date:  2004-05-15       Impact factor: 4.104

View more
  5 in total

Review 1.  Vascular mimicry: Triggers, molecular interactions and in vivo models.

Authors:  Stephen L Wechman; Luni Emdad; Devanand Sarkar; Swadesh K Das; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2020-07-16       Impact factor: 6.242

Review 2.  Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.

Authors:  H Wang; L Liang; J-Y Fang; J Xu
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

3.  Progression inference for somatic mutations in cancer.

Authors:  Leif E Peterson; Tatiana Kovyrshina
Journal:  Heliyon       Date:  2017-04-11

4.  Comprehensive Analysis of Therapy-Related Messenger RNAs and Long Noncoding RNAs as Novel Biomarkers for Advanced Colorectal Cancer.

Authors:  Jibin Li; Siping Ma; Tao Lin; Yanxi Li; Shihua Yang; Wanchuan Zhang; Rui Zhang; Yongpeng Wang
Journal:  Front Genet       Date:  2019-11-20       Impact factor: 4.599

5.  Genetic Variations in the Transforming Growth Factor-β1 Pathway May Improve Predictive Power for Overall Survival in Non-small Cell Lung Cancer.

Authors:  Hong Zhang; Weili Wang; Wenhu Pi; Nan Bi; Colleen DesRosiers; Fengchong Kong; Monica Cheng; Li Yang; Tim Lautenschlaeger; Shruti Jolly; Jianyue Jin; Feng-Ming Spring Kong
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.